Clinical Trials Directory

Trials / Completed

CompletedNCT05108649

Impact of Nicotine Messaging on Beliefs and Behavior

Study 2: Impact of Nicotine Messaging on Nicotine Beliefs and Tobacco Use Behavior

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
74 (actual)
Sponsor
Andrew Strasser · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the effect of nicotine messaging and nicotine content of study cigarettes on nicotine beliefs and subsequent use of tobacco and nicotine products.

Detailed description

This project will utilize a randomized, factorial design trial to examine the effects of nicotine messaging on nicotine harm beliefs and smoking behavior. After a 7-day period of smoking own preferred brand cigarettes, participants will begin a 28-day experimental period and will be randomized to one of four conditions: 1) Nicotine Corrective Messaging (NCM) + Reduced nicotine content (RNC) cigarettes, 2) NCM + normal nicotine content (NNC) cigarettes, 3) Delayed Control Messaging + RNC cigarettes, or 4) Delayed Control Messaging + NNC cigarettes. The investigators will aim to recruit and randomize 160 current, daily cigarette smokers (80 male, 80 female) in a 35-day protocol. Participants will be asked to attend 6 in-person sessions at the Center for Interdisciplinary Research on Nicotine Addiction (CIRNA) on Days 0, 7, 14, 21, 28 \& 35. Sessions will occur every 6-8 days.

Conditions

Interventions

TypeNameDescription
OTHERNicotine MessagingAfter completing a 7-day baseline period, participants will be randomized to a 28-day experimental period and will view nicotine corrective messaging at each in-person session or delayed control messaging at the final study session.
OTHERCigarette ConditionAfter completing a 7-day period of smoking own brand cigarettes, participants will be randomized to a 28-day experimental period and will receive reduced nicotine content (RNC) cigarettes or normal nicotine content (NNC) cigarettes.

Timeline

Start date
2022-03-02
Primary completion
2024-06-20
Completion
2024-06-20
First posted
2021-11-05
Last updated
2025-12-08
Results posted
2025-12-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05108649. Inclusion in this directory is not an endorsement.